Research Overview: CJC-1295 Growth Hormone Releasing Peptide
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analogue that has garnered significant attention in peptide research for its extended half-life and potent biological activity. This modified peptide incorporates drug affinity complex (DAC) technology, which significantly extends its plasma stability compared to native GHRH. Researchers at Stroid UK Shop can examine how this peptide’s unique structure allows for sustained research applications in growth hormone secretion studies. The 5mg presentation from Peptide Sciences provides researchers with sufficient material for comprehensive in-vitro investigations into peptide stability, receptor binding characteristics, and cellular response mechanisms.
Laboratory Investigation Applications
Laboratory studies with CJC-1295 focus primarily on its interaction with growth hormone-releasing hormone receptors and subsequent cellular signalling pathways. Research teams investigate this peptide’s ability to stimulate growth hormone release in controlled experimental conditions, examining both acute and sustained cellular responses. Scientists studying muscle-building peptides often incorporate CJC-1295 into comparative studies alongside other growth hormone secretagogues. The peptide’s extended half-life makes it particularly valuable for researchers examining long-term cellular adaptation mechanisms and growth factor regulation. Studies also evaluate its interaction with insulin-like growth factor pathways and protein synthesis markers in various cell cultures.
Technical Specifications and Research Parameters
| Parameter | Specification |
|---|---|
| Molecular Formula | C152H252N44O42 |
| Molecular Weight | 3367.97 g/mol |
| Purity | ≥98% (HPLC) |
| Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Maleimidocaproyl)-NH2 |
| Storage | -20°C, protected from light |
| Solubility | Water, pH 6-8 |
Research teams investigating selective androgen receptor modulators often compare CJC-1295’s growth-promoting mechanisms with other anabolic research compounds. The peptide’s stability profile allows for extended experimental protocols, making it suitable for researchers examining long-term cellular adaptations. Studies frequently analyse its synergistic effects when combined with other research peptides in controlled laboratory environments.
Laboratory Compliance and Research Guidelines
This CJC-1295 5mg preparation is manufactured by Peptide Sciences exclusively for in-vitro research applications. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with institutional guidelines and maintain appropriate documentation for all experimental protocols involving this research peptide.
